期刊
PROTEIN & CELL
卷 7, 期 6, 页码 417-433出版社
SPRINGEROPEN
DOI: 10.1007/s13238-016-0269-2
关键词
Alzheimer's disease; microglia; lysosomes; TFEB; SIRT1; deacetylation
类别
资金
- National Natural Science Foundation of China [31470807, 31270872, 31200610]
- National Basic Research Program (973 Program) [2010CB912203, 2011CB915504]
- Founds from State Key Laboratory of Protein and Plant Gene Research, College of Life Sciences, Peking University
Microglia play a pivotal role in clearance of A beta by degrading them in lysosomes, countering amyloid plaque pathogenesis in Alzheimer's disease (AD). Recent evidence suggests that lysosomal dysfunction leads to insufficient elimination of toxic protein aggregates. We tested whether enhancing lysosomal function with transcription factor EB (TFEB), an essential regulator modulating lysosomal pathways, would promote A beta clearance in microglia. Here we show that microglial expression of TFEB facilitates fibrillar A beta (fA beta) degradation and reduces deposited amyloid plaques, which are further enhanced by deacetylation of TFEB. Using mass spectrometry analysis, we firstly confirmed acetylation as a previously unreported modification of TFEB and found that SIRT1 directly interacted with and deacetylated TFEB at lysine residue 116. Subsequently, SIRT1 overexpression enhanced lysosomal function and fA beta degradation by upregulating transcriptional levels of TFEB downstream targets, which could be inhibited when TFEB was knocked down. Furthermore, overexpression of deacetylated TFEB at K116R mutant in microglia accelerated intracellular fA beta degradation by stimulating lysosomal biogenesis and greatly reduced the deposited amyloid plaques in the brain slices of APP/PS1 transgenic mice. Our findings reveal that deacetylation of TFEB could regulate lysosomal biogenesis and fA beta degradation, making microglial activation of TFEB a possible strategy for attenuating amyloid plaque deposition in AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据